课题基金 / 基金详情

项目摘要

项目成果

Gregoire Altan-Bonnet的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We developed quantitative models of the cell-to-cell communications via cytokines amongst population of T lymphocytes. Our goal is to understand how leukocytes self-organize to decide their cell fate (e.g. between quiescence -tolerance- and death/proliferation -responses). At a fundamental level, we developed theoretical tools to analyze the heterogeneity and synchronicity of T cell responses in dense tissues. In the context of responses to tumor, we found that a critical mass of T cells existed to drive tumor rejection. Additional work is being carried out to dissect quantitatively how T cell decide collectively between tumor rejection and tumor tolerance. We also made progress in the development of a microfluidic platform (collaboration with Don DeVoe within the NI/UMD partnership) to address spatial aspects of cell-to-cell communications. This platform allows the assembly of micro-immune reactions with tumor cells, T cell and macrophages, and the observation of the ensued immune responses. The platform is also designed to allow cell recovery towards off-chip analysis (e.g. scRNAseq and FACS).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Endogenous Heterogeneity of Signaling Pathways in Cancer
  • 批准号:
    8181559
  • 项目类别:
  • 资助金额:
    $15.03万
  • 财政年份:
    2010
  • 负责人:
    Gregoire Altan-Bonnet
  • 依托单位:
Variability of Cellular Responses to Growth Factors and Drugs During Tumorgenesis
  • 批准号:
    8181539
  • 项目类别:
  • 资助金额:
    $165.27万
  • 财政年份:
    2010
  • 负责人:
    Gregoire Altan-Bonnet
  • 依托单位:
Quantitative modeling of the phenotypic variability of individual T cells and the
  • 批准号:
    8306678
  • 项目类别:
  • 资助金额:
    $48.89万
  • 财政年份:
    2009
  • 负责人:
    Gregoire Altan-Bonnet
  • 依托单位:
Single Cell Measurement Core Facility
  • 批准号:
    8555278
  • 项目类别:
  • 资助金额:
    $34.01万
  • 财政年份:
    2009
  • 负责人:
    Gregoire Altan-Bonnet
  • 依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
  • 批准号:
    2022J011295
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2022
  • 负责人:
    王亚伟
  • 依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究